These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37898382)

  • 1. Changing Strategy Between Bridge to Transplant and Destination LVAD Therapy After the First 3 Months: Analysis of the STS-INTERMACS Database.
    Rali AS; Inampudi C; Zalawadiya S; Shah A; Teuteberg JJ; Stewart GC; Cantor RS; Deng L; Jacobs JP; Kirklin JK; Stevenson LW
    J Card Fail; 2024 Apr; 30(4):552-561. PubMed ID: 37898382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Teuteberg JJ; Stewart GC; Jessup M; Kormos RL; Sun B; Frazier OH; Naftel DC; Stevenson LW
    JACC Heart Fail; 2013 Oct; 1(5):369-78. PubMed ID: 24621968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.
    Park Y; Kim D; Yang JH; Cho YH; Choi JO; Jeon ES
    Korean J Intern Med; 2022 Mar; 37(2):340-349. PubMed ID: 34871480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between early ventricular arrhythmias and mortality in destination vs. bridge patients on continuous flow LVAD support.
    Jedeon Z; Cogswell R; Schultz J; Von Wald L; John R; Roukoz H
    Sci Rep; 2021 Sep; 11(1):19196. PubMed ID: 34584108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients.
    Miller RJH; Moayedi Y; Sharma A; Haddad F; Hiesinger W; Banerjee D
    ASAIO J; 2020 Apr; 66(4):394-398. PubMed ID: 31192848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
    Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
    J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy.
    Nakagawa S; Garan AR; Takayama H; Takeda K; Topkara VK; Yuzefpolskaya M; Lin SX; Colombo PC; Naka Y; Blinderman CD
    J Palliat Med; 2018 Sep; 21(9):1284-1289. PubMed ID: 29874117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HeartWare Ventricular Assist Device (HVAD): A Single Institutional 10-Year Experience.
    Gyoten T; Rojas SV; Fox H; Deutsch MA; Ruiz-Cano M; Hakim-Meibodi K; Gummert JF; Morshuis M; Schramm R
    Thorac Cardiovasc Surg; 2022 Sep; 70(6):482-492. PubMed ID: 35235989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers.
    Cascino TM; McCullough JS; Wu X; Pienta MJ; Stewart JW; Hawkins RB; Brescia AA; Abou El Ala A; Zhang M; Noly PE; Haft JW; Cowger JA; Colvin M; Aaronson KD; Pagani FD; Likosky DS;
    JAMA Netw Open; 2022 Nov; 5(11):e2240646. PubMed ID: 36342716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation.
    Kilic A; Chen CW; Gaffey AC; Wald JW; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1093-1101.e1. PubMed ID: 30017440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in health-related quality of life by implant strategy: Analyses from the Interagency Registry for Mechanically Assisted Circulatory Support.
    White-Williams C; Fazeli PL; Kirklin JK; Pamboukian SV; Grady KL
    J Heart Lung Transplant; 2020 Jan; 39(1):62-73. PubMed ID: 31787446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry.
    Krim SR; Vivo RP; Campbell P; Estep JD; Fonarow GC; Naftel DC; Ventura HO
    J Heart Lung Transplant; 2015 Jul; 34(7):912-20. PubMed ID: 25824553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.